This is in accordance with the underlying proteinopathy, as GRN and C9ORF72 genetic patients are associated with a TDP-43 deposition, whereas MAPT genetic patients are characterized by a tau protein deposition. The gene discussed is GRN; the disease is proteostasis deficiencies.